These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11837513)

  • 1. Multifactorial regulation of plasma natriuretic peptides calls for supplementary measurements.
    Lindstedt G
    Scand Cardiovasc J; 2001 Dec; 35(6):355-8. PubMed ID: 11837513
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
    Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
    Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of renal function in intensive care: plasma cystatin C vs. creatinine and derived glomerular filtration rate estimates.
    Le Bricon T; Leblanc I; Benlakehal M; Gay-Bellile C; Erlich D; Boudaoud S
    Clin Chem Lab Med; 2005; 43(9):953-7. PubMed ID: 16176176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystatin C, serum creatinine, and estimates of kidney function: searching for better measures of kidney function and cardiovascular risk.
    Levin A
    Ann Intern Med; 2005 Apr; 142(7):586-8. PubMed ID: 15809469
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic significance of cystatin C in patients with ST-elevation myocardial infarction.
    Ichimoto E; Jo K; Kobayashi Y; Inoue T; Nakamura Y; Kuroda N; Miyazaki A; Komuro I
    Circ J; 2009 Sep; 73(9):1669-73. PubMed ID: 19597298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystatin C: efficacy as screening test for reduced glomerular filtration rate.
    Herget-Rosenthal S; Trabold S; Pietruck F; Holtmann M; Philipp T; Kribben A
    Am J Nephrol; 2000; 20(2):97-102. PubMed ID: 10773608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystatin C in a high-risk combination.
    Iwanaga Y; Miyazaki S
    Circ J; 2009 Sep; 73(9):1593-4. PubMed ID: 19706985
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma proatrial natriuretic factor (1-98) concentration after myocardial infarction: relation to indices of cardiac and renal function.
    Bonarjee VV; Omland T; Nilsen DW; Caidahl K; Sundsfjord JA; Dickstein K
    Br Heart J; 1995 Jun; 73(6):511-6. PubMed ID: 7626348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
    Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
    Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current methods of estimating the glomerular filtration rate].
    Zelichowski G
    Pol Arch Med Wewn; 2001 Nov; 106(5):1093-7. PubMed ID: 12026525
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic significance of N-terminal pro-atrial natriuretic factor (1-98) in acute myocardial infarction: comparison with atrial natriuretic factor (99-126) and clinical evaluation.
    Omland T; Bonarjee VV; Nilsen DW; Sundsfjord JA; Lie RT; Thibault G; Dickstein K
    Br Heart J; 1993 Nov; 70(5):409-14. PubMed ID: 8260270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of plasma N-terminal proatrial natriuretic peptide (proANP) as an early predictor of outcome in unstable angina pectoris or non-ST-elevation acute myocardial infarction.
    Jernberg T; Stridsberg M; Lindahl B
    Am J Cardiol; 2002 Jan; 89(1):64-6. PubMed ID: 11779526
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma cystatin C as a marker of renal function in patients with liver cirrhosis.
    Randers E; Ivarsen P; Erlandsen EJ; Hansen EF; Aagaard NK; Bendtsen F; Vilstrup H
    Scand J Clin Lab Invest; 2002; 62(2):129-34. PubMed ID: 12004928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echocardiography or Nt-proANP in post-myocardial infarction patients: is one enough?
    Pinto FJ
    Eur Heart J; 2002 Jul; 23(13):996-7. PubMed ID: 12093047
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma levels of N-terminal proatrial natriuretic peptide in children are dependent on renal function and age.
    Holmström H; Hall C; Stokke TO; Thaulow E
    Scand J Clin Lab Invest; 2000 Apr; 60(2):149-59. PubMed ID: 10817402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic peptide biomarkers as information indicators in elderly patients with possible heart failure followed over six years: a head-to-head comparison of four cardiac natriuretic peptides.
    Alehagen U; Svensson E; Dahlström U
    J Card Fail; 2007 Aug; 13(6):452-61. PubMed ID: 17675059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between serial changes in left-sided heart chambers and atrial natriuretic peptide and N-terminal pro atrial natriuretic peptide after a first myocardial infarction. An echocardiographic study.
    Svanegaard J; Johansen JB; Klitgaard NA; Thayssen P; Haghfelt T
    Scand Cardiovasc J; 1999; 33(6):355-61. PubMed ID: 10622548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum chromogranin A and its relationship to endogenous markers of glomerular filtration rate.
    Mojiminiyi OA; George S
    Ann Clin Biochem; 1999 Mar; 36 ( Pt 2)():247-9. PubMed ID: 10370749
    [No Abstract]   [Full Text] [Related]  

  • 19. Summaries for patients. Can a new blood test help predict who is at risk for developing heart failure?
    Ann Intern Med; 2005 Apr; 142(7):I53. PubMed ID: 15809456
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the clinical application of cystatin C, a new marker of the glomerular filtration rate, for the initial dose-setting of arbekacin.
    Otsuka T; Tanaka A; Suemaru K; Inoue T; Nishimiya T; Murase M; Araki H
    J Clin Pharm Ther; 2008 Jun; 33(3):227-35. PubMed ID: 18452409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.